X

Xenios AG

138 employees

XENiOS AG developer of extracorporeal therapy systems.

Investor insights

Funding rounds participated in

$2.1M sweet spot round size

Most of their 2 investments are in rounds between $1.9M and $2.2M

Basic info

Industry

medical equipment manufacturing

Sectors

membrane oxygenation
ECLS
artificial lungs
Health Care
ARDS
Medos
multi organ support
ECMO
vascular access
medical device
Therapeutics
Novalung
circulatory support
blood pumps
AECOPD
Medical Device
Medical
lung failure
iLA
ECCO2R

Date founded

2013

Investments made

U

Undisclosed raised $2.2M on September 21, 2016

Investors: Xenios AG

U

Undisclosed raised $1.9M on February 22, 2016

Investors: Xenios AG

Funding rounds raised

X

Xenios AG raised undisclosed on September 24, 2015

Investors: Zukunftsfonds Heilbronn (ZFHN) / Born2Grow (B2G)

FAQ